Dr. Valerie Callender [Virtual]
Dermatologist, USA
Dr. Valerie Callender
Dr. Valerie D. Callender is a Board-Certified Dermatologist who is known for her sensitive and cutting-edge approach to the management of hair loss in women and the treatment of pigmentation disorders. Dr. Callender has performed leadership roles in many dermatological organizations, including the Women’s Dermatologic Society and the Skin of Color Society, which she is Past President of both societies, and has served on the Board of Directors and Executive Committee of the American Academy of Dermatology. Dr. Callender is the current President of the American Dermatological Association, the oldest Dermatologic Society in the United States. She is the Founder and Medical Director of the Callender Dermatology & Cosmetic Center and Founder and Principal Investigator for Callender Center for Clinical Research, which are in the Washington, DC metropolitan region. Dr. Callender received her medical degree from Howard University, where she also did her residency and currently serves as Professor of Dermatology at the College of Medicine. She is the recipient of the Women’s Dermatologic President’s Award and Mentor of the Year Award, and the Dermatology Foundation’s Clark W. Finnerud Award. The Clark W. Finnerud Award is given each year to an individual who has devoted extraordinary time and talent as a part-time teacher and clinician.
Mr. Dalvi Humzah
Plastic Surgeon, UK
Mr. Dalvi Humzah
Mr Dalvi Humzah is a Consultant Plastic with a degree in Anatomy and an MBA. He is a member of: BAPRAS, UKAAPS, ASPS and ISAPS, was voted Aesthetic Practitioner of the Year 2016-17, won multiple awards for teaching in Facial Aesthetics and awarded the Aesthetics Journal Award for Outstanding Achievement (2022). He was previously: STEP® Tutor for RCS England, Chairman of Medical Advisory Committee Nuffield Wolverhampton Hospital, Chairman of Greater Midlands Skin Cancer Group, Co-Chairman of UK Botulinum Toxin Group (Aesthetics), member of Private Practice Committee BMA, member Continuing Education Committee (ASPS), Chairman of the Educational Board of the British College of Aesthetic Medicine, Lead on the Clinical Advisory Board for the Aesthetics Journal and Co-Lead for e-LPRAS. He delivers the multi-award winning Dalvi Humzah Aesthetic Training courses: Advanced Facial Anatomy, Complications, Injectable Training and Training Aesthetic Clinical Trainers internationally. He is a founding member of the Academy of Clinical Educators at the RCPS Glasgow and is an examiner for the Royal College of Surgeons of Glasgow, and member of the ISAPS Residents Committee He presents nationally and internationally, is a Key Opinion Leader and Scientific Advisory Board Member to the Aesthetic Sector. He is Co-Editor for the PMFA Journal.
Dr. Hema Sundaram
Dermatologist, USA
Dr. Hema Sundaram
Dr Hema Sundaram is a fellowship-trained, American board-certified dermatologist, and founding director of her cosmetic dermatology, laser and surgery clinics in suburban Washington, D.C.,USA. She has a special interest in elucidating the scientific basis of new technologies, and a commitment to applying science in the service of patient safety. Dr Sundaram holds masters and medical degrees with honours from Cambridge University in England. She completed dermatology residency at the University of Chicago, post-doctoral research in molecular biology, and a medical staff research fellowship at the National Institutes of Health where she served as a lieutenant commander in the Commissioned Corpsof the USA Public Health Service. Dr Sundaram is a visiting professor for the American Society for Dermatologic Surgery (ASDS), co- chair of the ASDS International Traveling Mentorship and Fellowship Recognition Programs Work Group and appointed as a mentor for the ASDS Future Leaders’ Network to prepare the next generation of leaders in dermatologic surgery. She has received awards for her clinical and research work and her publications. She serves as a session director, moderator and faculty speaker at the ASDS and American Academy of Dermatology (AAD) annual meetings, on the ASDS Cutaneous Events Procedures Event Registry (CAPER) Task Force, the AAD Sulzberger Dermatologic Institute and Education Grants Committee, and the Skin of Color Society Development and Research Committees. She is a keynote speaker at plastic, oculoplastic and facial plastic surgery academy conferences. Dr Sundaram is a principal investigator for US FDA clinical trials of injectables, lasers, devices, and topical therapies, and an advisor on regulatory submissions, development of study protocols and assessment scales in North America, Europe, and Asia. She directs educational initiatives and conferences worldwide and founded the Global Aesthetics Alliance, which brings together dermatologists, plastic surgeons and scientists from throughout the world to forge collaborations that optimise procedural safety and outcomes.
Mr. Doug Abel
CEO, USA
Mr. Doug Abel
Doug has been actively engaged in bringing innovations to aesthetic medicine and dermatology for over 20 years, beginning with BOTOX® where he was the initial global lead for aesthetic applications. He currently serves as the President & CEO of Advanced Aesthetic Technologies, developing the agarose based deep structural filler Algeness® where he led the effort to obtain a key strategic partnership in China, obtain the more rigorous MDR CE Mark, and begin expanded commercial efforts globally. Prior to his current position, Doug served as President of Sinclair North America and was responsible for the launch of Sinclair’s first product in the US and the clinical and regulatory development and commercialization of Sinclair’s full product pipeline in the US and Canada. He earlier led the initial efforts to bring BOTOX® to the global aesthetic community while with Allergan and subsequently spearheaded Biogen’s program to bring the first biologic approved for psoriasis to market. He has also held senior leadership positions at several other startup dermatology and aesthetic companies. He holds a BA in Chemistry from Lafayette College and an MBA from Temple University.
Dr. Mimi Borelli
Scientist, USA
Dr. Mimi Borelli
Mimi R. Borrelli, MBBS, PhD, MSc, MBA (Cand.), serves as Associate Director and Franchise Lead for Belotero within Global Medical Affairs at Merz Aesthetics. She brings a unique blend of clinical expertise, scientific rigor, and industry leadership, with a background spanning plastic surgery practice, regenerative medicine research, and strategic medical affairs.
Mimi began her academic journey in the UK, earning a BSc in Experimental Psychology, an MSc in Cognitive Neuroscience, and an MBBS from King’s College London. Her passion for regenerative medicine led her to Stanford University, where she advanced research on skin stem cells, fibroblast heterogeneity, and wound healing—work that culminated in a PhD awarded by the Royal College of Surgeons in Ireland. Following her time in the lab, she trained as a Plastic and Reconstructive Surgery Resident at Brown University before transitioning to industry as a Medical Science Liaison at AVITA Medical, a leader in regenerative wound care.
Since joining Merz Aesthetics in October 2024, Mimi has spearheaded global initiatives to position Belotero through an innovative biomimicry framework, aligning scientific messaging across markets and driving differentiation. She has contributed to high-impact publications, secured visibility at major international congresses, and led educational programs that reinforce Merz’s thought leadership in aesthetics.
A prolific researcher, Mimi has authored over 100 peer-reviewed publications, secured multiple research grants, and presented at prestigious national and international conferences. Beyond her professional achievements, she is passionate about education, tutoring math and science for over a decade, and enjoys music, fine art painting, tennis, and yoga.
Dr. Tsing Cheng
Scientist, USA
Dr. Tsing Cheng
Tsing Cheng, Ph.D.
Director, Medical Affairs – SkinMedica
Allergan Aesthetics, an AbbVie company
Dr. Tsing Cheng obtained his Ph.D. degree in Medical Sciences and he has over a decade of skin biology research experience. After his postdoctoral research, he worked as a consultant before joining SkinMedica and Allergan in 2016.
Dr Cheng is involved in the development, launch, and support of innovative, evidence- based skincare products that improve skin quality as well as quality of life. He is responsible for the medical affairs & scientific communications strategy including advisory boards, scientific publications, videos, symposia, and education. He frequently presents on evidence-based skincare and is an author on numerous peer-reviewed publications.
Dr. Laura Cordero [Virtual]
Scientist, SPAIN
Dr. Laura Cordero
Dr. Laura Cordero, PhD, MSc
Dr. Laura Cordero is a Biomedical Scientist with a degree in Biomedicine from the University of Barcelona. She completed her bachelor’s thesis in pancreatic cancer research during a year abroad at the University of Manchester, UK. She then returned to Barcelona to pursue a Master’s in Advanced Immunology, focusing her research on type I diabetes in collaboration with the Clinical Hospital of Barcelona.
Awarded the prestigious Marie Skłodowska-Curie Fellowship, Dr. Cordero undertook her PhD at the University Hospital Regensburg, Germany. Her research sought to develop novel monoclonal antibodies to induce transplant tolerance, working in close partnership with the Immuno-Oncology and Biologics Engineering teams at AstraZeneca. As part of this work, she also served as a visiting scientist at AstraZeneca’s R&D site in Cambridge, UK.
Throughout her doctoral studies, Dr. Cordero was invited to speak at major international scientific meetings, including the International Transplant Science Conference (Germany), the Newcastle Tolerance Workshop (UK), and the Alicante Winter Immunology Symposium (Spain), where she received the Best Oral Communication Award.
She has contributed to EU Horizon 2020 forums as an invited speaker and received specialized training in Advanced Therapy Medicinal Product (ATMP) regulations through a workshop in The Netherlands, where she engaged with European Medicines Agency (EMA) experts on Scientific Advice and Interaction with Competent Authorities.
Dr. Cordero is an active member of the Marie Curie Alumni Association, the International Society for Extracellular Vesicles (ISEV), and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
Currently, she serves as Global Medical Advisor at Meta Cell Technology, leading international clinical research programs in real-world evidence, investigator-initiated trials, and post-market studies to strengthen scientific rigor and enhance product value.
She also holds a Master’s degree in Clinical Trials Monitoring and lectures at the Escuela Internacional de Medicina Estética y Cirugía, contributing to the Master’s program in Aesthetic Medicine and Plastic Surgery.
Dr. Laurin Council [Virtual]
Dermatologic Surgeon, USA
Dr. Laurin Council
M. Laurin Council, MD, MBA, FAAD, FACMS is a dermatologic surgeon in St. Louis, MO. She completed medical school and dermatology residency training at Washington University in St. Louis, MO, and a fellowship in minimally-invasive aesthetic procedures/micrographic surgery and dermatologic oncology (MSDO) at St. Louis University. She currently is on faculty at Washington University, where she is Director of Dermatologic Surgery and the Program Director of the MSDO fellowship. Her clinical and research areas of interest include rare non-melanoma skin cancers, aesthetic injectables, and laser therapy. She is a past member of the Board of Directors of the Women’s Dermatologic Society and the American College of Mohs Surgery. She currently serves on the Board of Directors of the American Academy of Dermatology and she is the current President of the American Society for Dermatologic Surgery. A strong believer in patient advocacy, she is a past President of the St. Louis Metropolitan Medical Society, the Speaker of the Missouri State Medical Association, and an ASDS Association Delegate to the American Medical Association. She serves on the Editorial Board of several dermatology journals including the Journal of the American Academy of Dermatology, Dermatologic Surgery, the International Journal of Women’s Dermatology, and Archives of Dermatological Research. She is a past editor in chief of Dialogues in Dermatology, the official podcast of the American Academy of Dermatology. She has authored over 90 peer- reviewed scientific papers and is the editor of 2 textbooks.
Dr. Gisele Donola
Orthodontic Surgeon & MD PhD Student, BRAZIL
Dr. Gisele Donola
Dr. Gisele Donola, a dental surgeon and Master of Dentistry specializing in orthodontics and facial harmonization, is a prominent professional in the field. Currently a medical student, Dr. Donola brings a unique interdisciplinary perspective to her practice. She has contributed extensively to scientific literature, focusing on material rheology, ultrasonography, and aesthetic complications.
As an advocate for evidence-based practices, Dr. Donola emphasizes safe procedures in aesthetic dentistry through her research and educational initiatives. She serves as a professor in specialization programs, guiding students in the prevention and management of aesthetic complications.
Internationally recognized, Dr. Donola is a sought-after lecturer at conferences and hands-on courses, sharing her insights on aesthetic dentistry and facial harmonization. Her expertise extends to courses utilizing fresh cadaver models in Brazil and the United States.
Dr. Gisele Donola has authored books on the topic of aesthetic complications and the utilization of ultrasonography, in addition to her numerous published articles. She also provides assistance in managing professional aesthetic complications in Brazil, Portugal, and Chile. Her dedication to advancing the field of aesthetic dentistry and facial harmonization is evident in her multifaceted contributions to research, education, and clinical practice, making her a respected authority in the global dental community.
Dr. Hawasatu Dumbuya
Scientist, USA
Dr. Hawasatu Dumbuya
Dr. Hawasatu Dumbuya is a research scientist, trained as a cell biologist & physiologist with expertise in clinical research for skincare product evaluation. She holds a B.S in Pharmacology & Toxicology from MCPHS University (2013) and a Ph.D. in Molecular Pharmacology & Physiology from Brown University (2017); her doctoral thesis work focused on ultraviolet light-induced melanin synthesis in human melanocytes. Post her studies, Dr. Dumbuya soon joined L’Oreal USA Research & Innovation, where she led the team efforts on developing novel concepts, methods, and protocols for clinical evaluations of new skincare ingredients. Currently leading Clinical Research & Medical Affairs for US La Roche-Posay at L’Oreal, her work has been focused on integrating methodologies and developing strategies for inclusive and comprehensive clinical testing for skincare products, plus establishing scientific educational programs with diverse audiences. Dr. Dumbuya research on skin pigmentation, photoprotection, atopic dermatitis has brought forth new clinical knowledge on diverse ethnically populations and has been published in peer-reviewed dermatology literature, plus presented in various research and dermatology congresses. Her research interests lie in understanding molecular mechanisms underlying different biological processes and their impact on patients’ quality of life, plus product development. Dr. Dumbuya is also passionate and active in community outreach to encourage STEM education and opportunities to under- represented students, in which she has received several prestigious awards for her scholastic and community outreach impact.
Dr. Ferial Fanian
Dermatologist, FRANCE
Dr. Ferial Fanian
Dr. Ferial Fanian is a dermatologist and expert in cutaneous imaging techniques (confocal microscopy, OCT, and high frequency ultrasound) and has been a board member of the imaging group of the French Society of Dermatology since 2015. She holds a PhD in Life and Health Science from the University of Franche Comté in France in 2016 where she worked for more than five years on primary human melanocytes. She is the co-editor of the textbook of skin biometrology, Agache’s Measuring the Skin, published in 2017 in the major reference category of Springer. She has been a researcher in this field for more than 10 years, including seven years as a scientific expert and coordinator at the Centre for Studies and Research on Integument (CERT) at the Department of Dermatology at University Hospital of Besançon, France. She is also author of several chapters in dermatology books including Atlas of Dermatology, Dermatopathology and Venereology and Gender Dermatology.
Thanks to her outstanding experience in aesthetic injections and laser application in dermatology, she is the scientific director of one of the FILLMED Laboratories in France. She is also a trainer and speaker at several international congresses and events and academic trainer since 2012 for the University Diploma Curriculum (DIU) in Cosmetic Dermatology, Dermatological Laser and Cosmetology in France.
Dr. Fanian is a reviewer for several English and French scientific journals such as JEADV, Archives of Dermatology, Skin and Research Technology, Journal of Cosmetic Dermatology, Case Reports in Dermatological Medicine and Therapeutic Realities in Dermato-Venereology.
Dr. David Funt
Plastic Surgeon, USA
Dr. David Funt
Dr. David K. Funt is a board-certified plastic surgeon recognized for his expertise in both surgical and nonsurgical cosmetic procedures. Certified by the American Board of Plastic Surgery, he is an active member of the American Society of Plastic Surgeons and the American Society for Aesthetic Plastic Surgery, and he is a Fellow of the American College of Surgeons.
Dr. Funt lectures nationally and internationally on facial anatomy, injectable techniques, and the prevention and management of complications related to facial fillers. He is considered a leading authority in this area and has published extensively in peer-reviewed journals, book chapters, and the popular press. He also teaches courses on anatomy as it relates to fillers and neurotoxins.
He earned his BS with distinction from Cornell University and his MD with distinction from The George Washington University School of Medicine and Health Sciences, where he was inducted into Alpha Omega Alpha. He completed his general and plastic surgery residencies at Montefiore Hospital and Medical Center and the Hospital of the Albert Einstein College of Medicine, with additional specialized training in burn and microvascular surgery.
Dr. Funt serves as an Assistant Clinical Professor of Plastic Surgery at the Icahn School of Medicine at Mount Sinai and holds a Certificate of Advanced Education in Cosmetic Surgery from The Aesthetic Society. He is a national instructor for Galderma and Merz, and serves as an adverse event consultant for Galderma, Merz, and Revance. He is also a founding member of the Liquid Facelift Association.
He maintains offices in Woodmere and Roslyn Heights, New York. His Woodmere surgical facility is accredited by the American Association for the Accreditation of Ambulatory Surgical Facilities, and his team of anesthesiologists, physician assistants, nurses, and medical staff is committed to delivering safe, compassionate, and comprehensive patient care.
Ms. MaryAnn Guerra
CEO, USA
Ms. MaryAnn Guerra
MaryAnn Guerra, CEO and Founder, Aesthetics Biomedical, Inc.
MaryAnn Guerra, founder of Aesthetics Biomedical®, has a history of creating organizations that yield results and advance innovation. Her career has focused on taking important scientific outcomes and translating them to medical products that serve the patient. Aesthetics’ Biomedical is designed to prevent and delay the signs of aging using personalized and precision technology. Since founding the company, Aesthetics Biomedical has internally developed two unique products, both made in the USA. SoME® Skincare using an individual’s own platelet rich plasma is the first skincare product that is inherently biocompatible and uniquely tailored to the individual, for at-home use. The UltraVisionTM RF Microneedling device utilizes ultrasound imaging guidance to improve radiofrequency treatments for personalized and safer outcomes.
Guerra’s previous comprehensive experience includes co-founding BioAccel, a non-profit organization accelerating the formation of successful biomedical device start-up companies and as the Chief Operating Officer of the Translational Genomics Research Institute. Ms. Guerra’s impressive career also includes senior leadership roles at the National Institutes of Health including Director of Technology Transfer, National Institute of Allergy and Infectious Diseases; Executive Officer, National Heart, Lung and Blood Institute; and Deputy Director of Management, National Cancer Institute.
Her quest to pursue innovation that makes a difference in public health drives her constantly.
Dr. Thomas Hengl
Scientist, GERMANY
Dr. Thomas Hengl
Dr. Thomas Hengl, PhD Molecular & Cell Biology
Dr. Thomas Hengl is a seasoned scientific leader with over a decade of experience in dermatological research and nonclinical science. He currently serves as Senior Director of the Skin Lab & Nonclinical Science Department at Merz Aesthetics, where he has been instrumental in advancing innovative approaches in aesthetics and skin biology since joining the company in April 2011.
Dr. Hengl holds a Diploma in Biology from the University of Heidelberg and earned his PhD in Molecular Physiology from the same institution. His early career included a Postdoctoral position at the University of Heidelberg and a brief tenure at Viscofan BioEngineering, where he gained valuable experience in bioengineering applications.
Dr. Hengl began his career at Merz Aesthetics as a scientific expert in biopharmaceutical dermatology, where he used preclinical models to characterize, develop, and optimize topical and injectable formulations. Over time, his expertise and strategic vision led to his appointment as Head of Skin Lab & Nonclinical Science, where he is responsible for a wide range of tasks, from developing innovative product ideas in the field of aesthetics to biological safety assessment of products in development and further scientific characterization of the mode of action of existing products.
Thanks to his deep expertise in skin biology, translational science, and drug innovation he has been pivotal not only in shaping the strategic direction of R&D Merz Aesthetics but also in driving innovation in nonclinical research.
Dr. Omar A. Ibrahimi [Virtual]
Dermatologist, USA
Dr. Omar A. Ibrahimi
Dr. Omar A. Ibrahimi is the founding and medical director of the Connecticut Skin Institute. He is a board certified Dermatologist who has completed advanced fellowship training in Skin Cancer, Laser and Cosmetic Surgery. Dr. Ibrahimi has trained at the most prestigious medical institutions in the country. He is one of the foremost physicians in the diagnosis and treatment of all types of skin cancer, as well as medical and cosmetic issues involving the skin. He has been honored as a Castle-Connolly Top Doctor since 2016 for his outstanding patient care.
Dr. Ibrahimi attended New York University for both his undergraduate and medical school education. He is a graduate of the rigorous MD-PhD program and was honored with the Sulzberger award given to the top graduating medical student in dermatology. He then completed his Dermatology training at Harvard Medical School working at Massachusetts General Hospital, Brigham and Women’s Hospital, Beth Israel Deaconess Medical Center, Children’s Hospital of Boston, Dana Farber Cancer Institute and the Boston Veteran’s Hospital. Omar then completed a fellowship program in Mohs and Reconstructive Surgery, Laser and Cosmetic Surgery at the University of California – Davis.
Dr. Omar Ibrahimi is accredited by the American College of Mohs Surgery, the American Society for Dermatologic Surgery, the American Society for Lasers in Surgery and Medicine and the American Academy of Dermatology. He is well-known nationally and internationally, having been an invited speaker at numerous national meetings, and has written extensively about Mohs Surgery, Laser and Cosmetic Procedures. Dr. Ibrahimi has published many articles on skin cancer surgery, laser and cosmetic procedures in leading medical journals. He has also performed tens of thousands of cases of Mohs Surgery and Laser and Cosmetic procedures. Dr. Ibrahimi has been responsible for unveiling and optimizing many of the latest cosmetic procedures that have hit the market in recent years and his practice is among the first to receive the latest innovations in aesthetic dermatology.
Dr. Ibrahimi has served as a Visiting Assistant Professor of Dermatology at Harvard Medical School in the Wellman Center for Photomedicine. The Wellman Center for Photomedicine is the world’s leading research center, where the majority of today’s laser and cosmetic technologies were invented and tested. He is an active participant in many clinical trials of new technologies. Prior to founding the Connecticut Skin Institute, Dr. Ibrahimi was also an Assistant Professor of Dermatology, Dermatologic Surgery and Mohs Surgery at the University of Connecticut, and served as the Director of Laser and Cosmetic Surgery.
Dr. Ibrahimi prides himself on treating his patients, not just their skin cancer or cosmetic concerns. His goal is to provide you with the best possible medical care in a friendly office environment.
Mr. Murray Jensen
Regulatory Specialist, CANADA
Mr. Murray Jensen
Murray Jensen is the Managing Director of ethica CRO, a contract research organization specializing in clinical research for medical aesthetics. With over 20 years of experience in injectables (dermal fillers, botulinum toxins), energy-based devices, cosmeceuticals, and advanced skin therapies, he has led the design and execution of clinical trials supporting regulatory approvals, product claims substantiation, and scientific validation. His expertise includes trial methodology, regulatory compliance, and the integration of real-world evidence (RWE) into medical aesthetics research. Murray is also a standing member of the Human Research Standards Organization (HRSO) Technical Steering Committee, a non-profit standards development organization accredited by the Standards Council of Canada. HRSO’s mission is to develop National Standards that guide the ethical, scientific, and regulatory aspects of human research in Canada. By promoting harmonization and collaboration, these standards strengthen oversight, participation, and economic growth in human research both nationally and internationally.
Dr. Martin Kassir
Dermatologist, USA
Dr. Martin Kassir
Dr. Martin Kassir is board certified in dermatology and specializes in aesthetic dermatology and laser procedures. He opened his elite dermatological practice in Dallas in 2000. As an internationally recognized speaker and educator on aesthetic procedures, Dr. Kassir has lectured and conducted seminars in over 50 countries on six continents. He has also served as course instructor on lasers and IPL, Microneedling, BOTOX®, Dysport®, XEOMIN, Fillers, Threads, Radiofrequency devices and other EBDs. Local, national, and international dermatologists and doctors rotate through Dr. Kassir’s office to learn the latest esthetic and laser procedures. Dr. Kassir is founder and Director of Worldwide Laser Institute, a school for esthetics in the state of Texas. This school initially was founded for the purposes of certification of Laser Hair Removal technicians, but has grown internationally with courses all over the world. Dr. Kassir is a Diplomat of the American Board of Dermatology and author of over 60 peer-reviewed publications. https://pubmed.ncbi.nlm.nih.gov/?term=kassir+martin Dr. Kassir is the past vice president and current Treasurer of the International Society of Dermatology (ISD). He has served as Chairman of the ISD Mentorship Committee, whose goal is to promote the advancement and exchange of scientific and clinical dermatologic information worldwide for the purpose of providing better patient care on every continent. Dr. Kassir is also the Founding Chair of the ISD’s Global Outreach Task Force with the mission of bringing dermatologic care to underserved areas of the world. Dr. Kassir received his MD and was trained in Internal Medicine at UT Southwestern Medical Center and Dermatology at Kansas University Medical Center.
Prof. James Kirkland
Gerontologist, USA
Prof. James Kirkland
James L. Kirkland, M.D., Ph.D., is Director of the Center for Advanced Gerotherapeutics at Cedars-Sinai Medical Center, Los Angeles and Emeritus Professor of Medicine at Mayo Clinic, Rochester, Minnesota. Dr. Kirkland’s research is on the contribution of aging processes, particularly cellular senescence, to multiple disorders and diseases across the lifespan and development of gerotherapeutics: agents and strategies for targeting these aging mechanisms to delay, prevent, alleviate, or treat the conditions that cause the bulk of disability, mortality, and health expenditures across the developed and developing world. Dr. Kirkland discovered senolytic drugs, agents that selectively eliminate senescent cells. Dr. Kirkland and then others demonstrated that senolytic agents enhance healthspan and treat multiple diseases in animal models, human cells, and tissue explants. He published the first composite biomarker gerodiagnostic score of senescent cell burden that is sensitive to drug interventions in humans and the first clinical trials of senolytic drugs. He is preparing or conducting clinical studies of senolytics, including for infections, frailty, Alzheimer’s disease, diabetes/obesity, osteoporosis, cancer survivors, idiopathic pulmonary fibrosis, pre-eclampsia, glioblastoma, complications of space travel, agricultural applications, restoring function of organs from old donors to enable their use for transplantation, and others. He has more than 330 publications (H index: 110) and holds 24 patents. Dr. Kirkland is Principal Investigator of the National Institutes of Health Translational Geroscience Network (R33 AG061456), which brings together academic institutions across the US to translate healthspan interventions, including senolytics and other drugs that target fundamental aging processes, from bench to bedside, and is currently involved in over 85 interventional and observational clinical trials. He is President-Elect of the Healthy Longevity Medicine Society, immediate past President of the American Federation for Aging Research, a past member of the National Advisory Council on Aging of the National Institutes of Health, past chair of the Biological Sciences Section of the Gerontological Society of America, and past member of the Clinical Trials Advisory Panel of the National Institute on Aging. He is a board-certified specialist in internal medicine, geriatrics, and endocrinology and metabolism. Dr. Kirkland is the 2020 recipient of the Irving S. Wright Award of Distinction from the American Federation for Aging Research.
Dr. Rob Knight
Scientist, USA
Dr. Rob Knight
Dr. Rob Knight, PhD is Lead Scientist and Head of R&D at Cellese Inc. (AnteAGE), a regenerative aesthetics company based in Irvine, California. He leads translational research, product development, clinical strategy, and advanced characterization programs focused on stem cell–derived exosomes, synthetic exosome-inspired nanoparticles (Biosomes™), growth factors, and next-generation regenerative technologies.
With over a decade of experience in regenerative medicine, Dr. Knight specializes in extracellular vesicle biology, tissue repair, and scar modulation. His early work at UCLA focused on stem cell and exosome-based therapies for corneal scarring, and his PhD from Cardiff University investigated small extracellular vesicles (exosomes) as anti-scarring therapeutics.
At Cellese, he oversees a multidisciplinary science team driving in vitro, ex vivo, and clinical validation programs to support product claims and innovation. He plays a key role in long-term R&D strategy, clinical trial design, and board-level scientific communication, helping position Cellese at the forefront of regenerative aesthetics.
Dr. Arianne Shadi Kourosh
Dermatologist, USA
Dr. Arianne Shadi Kourosh
Dr. Kourosh is a board certified dermatologist and an Associate Professor at Harvard Medical School and the Harvard School of Public Health. As the founding director of Massachusetts General Hospital’s (MGH) Dermatology Division of Community Health, Dr. Kourosh has built and led the division providing access to dermatologic care for underserved communities and multiple community programs to serve them. As the founding director of MGH’s Skin of Color Program, Dr. Kourosh created a medical home and center for research for skin conditions disproportionately affecting people of color. She is the founder and director of Harvard’s pro-bono laser clinic and tattoo removal program assisting those escaping gangs and human trafficking become safe and reintegrate into society, winning national awards for its impact, and chaired the American Academy of Dermatology’s task force on human trafficking.
Dr. Kourosh has been elected to the Board of Directors of the American Academy of Dermatology (AAD), and served in the AAD’s delegation to Congress and a national task force interfacing with the FDA on healthcare economics and access to affordable medications for patients with skin disease. Dr. Kourosh developed the Skin Advocate iPhone app, a free app connecting patients with advocacy organizations for their skin conditions.
Dr. Kourosh has served as Editor in Chief of Dialogues in Dermatology, the official podcast and medical education program of the American Academy of Dermatology, educating thousands of physicians around the world. She is the Editor of the Medical Humanities section of the Journal of the American Academy of Dermatology, and a contributing writer for Harvard Health and US News & World Report. She authored the Facing Skin Conditions series of books to help people with conditions such as psoriasis, eczema, vitiligo, acne, burns and scars, navigate their wellness journey, featured by the National Psoriasis Foundation.
Dr. Kourosh’s research at the intersection of dermatology and public health — including her pioneering work on Zoom dysmorphia, skin impacts of the Covid19 vaccine, climate factors and pollution impacts on skin diseases and aging, especially in vulnerable populations, and on the skin signs of human trafficking — has reached national and international impact, and has been featured on the Today Show, The Daily Show, PBS, and Boston Globe Media, and in Oprah magazine, Reader’s Digest, The Huffington Post, and Wired magazine, among numerous others, and for which she has been a featured speaker at the Aspen Ideas Festival.
Dr. Kourosh served as Director of the Center for Lasers and Aesthetics in the Department of Dermatology at Brown before joining a premier aesthetic dermatology clinic on Park Avenue and now serving as Director of Aesthetics for Nantucket Cottage Hospital, where she practices and publishes research, lectures globally at the intersection of aesthetics, longevity and regenerative medicine.
Dr. Kourosh has won numerous awards including MGH’s Clinician-Teacher Award, Harvard Medical School’s Dean’s Community Service Award, and Boston’s Top Doctors. In 2020 she received the AAD’s Presidential Citation for outstanding service during the COVID19 crisis, and then presidential citations again from the AAD and American Society for Laser Medicine and Surgery (ASLMS) for her advocacy for patients affected by human trafficking, and the International League of Dermatology Society’s Humanitarian Award for global leadership in building medical infrastructures to assist patients affected by trafficking and she has been named one of Medscape’s 25 Rising Stars in Medicine.
Dr. Kavita Mariwalla [Virtual]
Dermatologist, USA
Dr. Kavita Mariwalla
Dr. Kavita Mariwalla is a board-certified dermatologist and nationally recognized key opinion leader in dermatology and dermatologic surgery. Her expertise is in the areas of anti-aging procedures and skin cancer treatment. She is sought after for opinions on cosmetic formulations and is regularly invited as a featured speaker in the United States and overseas.
Prior to starting her own private practice, Dr. Mariwalla was the Director of Cutaneous Oncology at St. Luke’s – Roosevelt and Beth Israel Medical Centers in New York. Dr. Mariwalla has been recognized for extensive work in the area of dermatologic education and is considered an expert injector of fillers and neuromodulators. She has written two editions of the widely used book, Primer in Dermatologic Surgery, which is highly regarded by residents and seasoned dermatologic surgeons. Most recently, she authored the Cosmeceutical Compendium, an encyclopedic guide on ingredients commonly used in cosmetic formulations. In addition to authoring several books, Dr. Mariwalla is editor of “Surgical Pearls” for the Journal of the American Academy of Dermatology and is Secretary of the American Society for Dermatologic Surgery. She has served on the Board of Directors of the Women’s Dermatologic Society and American Society for Dermatologic Surgery in the past and is a three-time recipient of the ASDS President’s Award for outstanding contributions to the field of dermatologic surgery. Dr. Mariwalla earned her degree in medicine at the Yale School of Medicine where she also completed her dermatology residency and fellowship training.
When not working, you can find Dr. Mariwalla building legos with her three boys and trying to perfect pizza on the BBQ alongside her husband Kabir.
Dr. Rahul Mehta
Scientist, USA
Dr. Rahul Mehta
Dr. Rahul C. Mehta, Ph.D.
Co-Founder and CEO, Rapalogix Health Inc
Dr. Rahul C Mehta is the Co-Founder and CEO of Rapalogix Health, a biopharma company that leverages insights from longevity science for dermatology and aesthetic medicine. He earned his Doctorate in Pharmaceutical Sciences from West Virginia University and holds a bachelor’s degree in pharmacy from the University of Bombay. With more than 35 years of experience in pharmaceutical research and development, including six years in academia, Dr. Mehta has written or contributed to over 80 research publications and book chapters, presented at more than 200 conferences, and holds multiple patents in pharmaceutical sciences. Before founding Rapalogix, he led the SkinMedica R&D team from 2005, successfully guiding its integration first into Allergan and later Abbvie. Dr. Mehta is dedicated to developing holistic, evidence-based skincare solutions focused on skin longevity, backed by robust biological and clinical data. His work aims to move beyond simply addressing aging symptoms by exploring the biological mechanisms of skin aging, quality changes due to aging, and the impact of diversity, ultimately supporting the skin’s natural regenerative abilities for balanced, long-term health.
Dr. Jose Raul Montes [Virtual]
Oculofacial Surgeon, USA
Dr. Jose Raul Montes
José Raúl Montes, MD, FACS, FACCS
Medical Director | José Raúl Montes Eyes & Facial Rejuvenation
Professor | University of Puerto Rico, School of Medicine, Department of Ophthalmology
Dr. José Raúl Montes obtained his Medical Degree and completed his Residency/Internship in Ophthalmology at the University of Puerto Rico, School of Medicine. He then completed his Fellowship in Oculoplastic Surgery at the University of Cincinnati. He is licensed by the Puerto Rico Medical Board, the New York Medicine and Surgery Board, and the Florida Medical Board.
Dr. Montes is certified by the American Board of Ophthalmology, licensed by the Puerto Rico Medical Board, the New York Medicine and Surgery Board, and the Florida Medical Board. He is a Fellow of the American Academy of Cosmetic Surgery, American Academy of Ophthalmology, American College of Surgeons, and American Society of Ophthalmic Plastic & Reconstructive Surgery. He is also a Member of American College of Surgeons Association, Colegio de Médicos Cirujanos de Puerto Rico, PanAmerican Association of Ophthalmology, and Puerto Rico Society of Ophthalmology, as well as an Honorary Affiliate of the American Society for Dermatologic Surgery.
With over 30 years’ experience and as member of various Advisory Boards for several pharmaceuticals companies, he has overseen the process of introducing new products for FDA‑approval into the United States. He is an established top injector, author, researcher, international speaker and trainer. He has numerous publications in medical journals and contributions in medical books.
In addition to having a successful practice in San Juan, Puerto Rico, which includes a Research and Training Center, in his role as a Professor of the University of Puerto Rico School of Medicine, Dr. Montes serves as a mentor to medical residents at the Río Piedras Medical Center.
Dr. Alexandra Mora
Facial Plastic Surgeon, COLOMBIA
Dr. Alexandra Mora
Alexandra Mora is a distinguished Colombian otolaryngologist and facial plastic surgeon, specializing surgical and non surgical rejuvenation procedures. With surgical precision, she transforms faces and lives—yet in writing, she found a deeper way to explore what the body reveals… and what it conceals.
Dr. Alexandra Mora Hernández is a board-certified otolaryngologist and facial plastic surgeon with over 30 years of clinical and surgical experience. She earned her medical degree from Universidad del Rosario, where she also completed her residency in Otolaryngology. She later pursued a Clinical Fellowship in Facial Plastic Surgery at Universidad CES, one of the leading training programs in Latin America, under the direction of Dr. Fernando Pedroza, a pioneer of Facial Plastic Surgery in Colombia and a highly respected international authority in the field.
Dr. Mora Hernández has held prominent leadership positions, including President of the Colombian Society of Facial Plastic Surgery and Rhinology (SCCPFR). She currently serves as Vice President of Facialis Academy.
Her professional practice is defined by a comprehensive, ethical, and patient-centered approach, with a strong commitment to medical excellence. She offers both surgical and non-surgical treatment options based on scientific evidence, prioritizing natural results, safety, and the highest quality standards.
She has received multiple national and international awards in recognition of her contributions to Facial Plastic Surgery and to the advancement of minimally invasive facial rejuvenation procedures.
Dr. Mora Hernández is currently dedicated to her private practice, focusing on Facial Plastic Surgery, laser medicine, cosmeceuticals, invasive and non-invasive facial rejuvenation. She is an active international speaker and visiting professor, participating in congresses, symposia, workshops, webinars, and advanced training courses worldwide.
She has published scientific articles, book chapters, and academic texts in peer-reviewed and professional medical journals. In non-fiction, she shares as an author her scientific expertise through Manual de Cosmeceútica para Médicos, Love Yourself, and Radiant Forever—guides to radiant, conscious aging.
Dr. Gilly Munavalli
Dermatologist, USA
Dr. Gilly Munavalli
Dr. Gilly Munavalli is a native of North Carolina and medical director/founder of Dermatology, Laser & Vein Specialists of the Carolinas in Charlotte, NC. He also currently serves as Assistant Clinical Professor of Dermatology at the Wake Forest University Department of Dermatology, working closely with residents in training on a regular basis. Dr. Munavalli received his Bachelor of Science from the University of North Carolina-Chapel Hill, Master of Health Science from the Johns Hopkins University School of Public Health, and Internship training at the Mayo Clinic. Dr. Munavalli trained in Dermatology at Emory University and later completed his Dermatologic surgery fellowship in Mohs Micrographic Surgery & Cutaneous Facial Reconstruction, Cosmetic Surgery at the University of California-San Francisco. He also completed a fellowship in phlebology & advanced laser surgery at the Maryland Laser, Skin Institute. Dr. Munavalli received his Board Certification in Dermatology in 2002 and recertification in 2012. He completed board certification in Mohs Surgery in 2022. He has over 90 scientific publications and book chapters and has served as principal investigator in a broad range of clinical research trials and 10 FDA pivotal trials.
Dr. Munavalli’s memberships and academic affiliations include:
Board certified and Fellow of American Academy of Dermatology
Board Certified and Fellow of the American College of Mohs Surgery
Fellow – American Society for Laser Medicine and Surgery
Fellow – American Society for Dermatologic Surgery
Academic affiliation – Assistant Clinical Professor of Dermatology at the Wake Forest University Department of Dermatology
Author of over 90 peer reviewed publications and has given over 275 lectures nationally and internationally.
Editorial Board of LSM Journal and Lasers in Medical Science
Board of Directors – Intersocietal Accreditation Commission
Dr. Foad Nahai
Plastic Surgeon, USA
Dr. Foad Nahai
Foad Nahai, MD FACS FRCS (Hon) FRCST (Hon)
Dr. Foad Nahai is editor emeritus of Aesthetic Surgery Journal, formerly the Maurice J Jurkiewicz chair in Plastic Surgery and professor of Surgery at Emory University. He practices at the Center for Plastic Surgery at Metroderm in Atlanta Georgia USA. He is internationally recognized as an innovator in the field of plastic surgery where he has developed and refined many procedures. He has co-authored 14 books and published over 310 scientific articles on all aspects of plastic surgery. The latest book he authored and edited, published in 2020, is the third edition of his three-volume text entitled The Art of Aesthetic Surgery. Dr. Nahai is a past President of the American Association for Accreditation of Ambulatory Surgical Facilities (QUAD A), a past president of the American Society for Aesthetic Plastic Surgery (ASAPS) past president of the International Society of Aesthetic Plastic Surgery (ISAPS), past chair of the Plastic surgery Research Council and has served as a director of the American Board of Plastic Surgery. He was presented with Honorary Fellowship in the Royal College of Surgeons of England in 2016.
He is listed in the “Best Doctors in America”, the “Best Doctors in the U.S.”, Town & Country Magazine, Good Housekeeping, More Magazine and Atlanta Magazine as one of the country’s top plastic surgeons. He has been listed in W Magazine as one of the top plastic surgeons in the world. He is listed amongst the top plastic surgeons in the US by Newsweek. Dr. Nahai is in demand internationally to speak at plastic surgery meetings and to demonstrate surgical procedures.
His primary area of expertise is in face, neck and eyelid surgery where he has made significant contributions to the advancement of the art and science of Facial Rejuvenation. Additional areas of experience include: injectables, breast surgery, abdominoplasty and skin resurfacing.
He is a strong advocate of evidence-based medicine (EBM) both in his own clinical practice and within the Aesthetic Surgery Journal for the articles selected for publication where he helped initiate the EBM HUB section that is dedicated to educating plastic surgeons about the benchmarks, challenges, and nuances of EBM. Dr. Nahai has presented on and champions research that promotes and advances patient safety and positive outcomes through his work with the QUAD A.
Dr. Dawn Naylor
Imaging Specialist, USA
Dr. Dawn Naylor
Dr. Dawn Naylor is a Doctor of Nursing Practice and Board-Certified Acute Care Nurse Practitioner with over 25 years of experience in the field of aesthetic medicine. She is the founder and owner of the multi-award-winning Skin Esteem Med Spa & Wellness Center in Kingston, Massachusetts.
Dr. Naylor’s commitment to clinical excellence is evidenced by her continuous advanced training with leaders in plastic surgery, dermatology, and medical aesthetics. Her expertise has earned her repeated recognition as one of the Top 100 Injectors in the United States, and her practice has been consistently honored with accolades, including Best Med Spa and Best Injectables for the past seven years.
Dr. Naylor completed her doctoral studies under the distinguished mentorship of Dr. Peter Velthuis. Her doctoral quality improvement project, “Integrating Ultrasound into Medical Aesthetics,” conducted in collaboration with Dr. Velthuis, was published in the Journal of the American Academy of Dermatology (JAAD).
As a national speaker and private trainer, Dr. Naylor is deeply involved in aesthetic safety initiatives grounded in evidence-based practice. She is highly regarded for her expertise in facial ultrasound and is a sought-after consultant for aesthetic providers globally, particularly in the management of complications and ultrasound education.
Dr. Naylor currently serves as a trainer in Cutaneous Facial Ultrasound and continues to lead safety research and innovation initiatives in collaboration with international experts, including Dr. Velthuis and Dr. Schelke. Her passion for advancing aesthetic medicine through education, safety, and technology continues to shape best practices in the field.
Dr. Francis Peart
Consultant Plastic Surgeon, UK
Dr. Francis Peart
Mr. Francis Peart (BSc hon, FRCS, FCS Plastic surgery) is the originator of the Surgical Sculpture teaching paradigm, and with the help of his co-director and colleague Mr Tom Pidgeon has developed the principle of constructive anatomy to provide high fidelity training in complex human anatomy. He was a Plastic surgery consultant in Johannesburg, South Africa before taking up a post in Birmingham which included leading the plastic surgery reconstruction of lower limb trauma and sarcoma patients. He has always been and remains a passionate sculptor, something that has driven his wish to use creative anatomical assembly as a tool for appreciating the three dimensional construct of the human body.
Dr. Thomas Pidgeon
Consultant Plastic Surgeon, UK
Dr. Thomas Pidgeon
BMedSc (Hons), MBChB (Hons), MSc, FRCS (Plast)
Tom is a Consultant Plastic Surgeon. He has worked with and developed Surgical Sculpture since 2018. Tom’s view of anatomy and surgical training is that it is an ever evolving journey, with constant iterative improvements applied throughout an entire career. Tom’s hope is that Surgical Sculpture will improve the confidence and competence of clinicians seeking to enhance their practice, for the betterment of the care they can provide to their patients.
Dr. Thomas Rappl
Plastic Surgeon, AUSTRIA
Dr. Thomas Rappl
Thomas Rappl, MD, is a Board Certified Plastic Surgeon, born in Graz, Austria. He is now working in the Medical University hospital Graz as a Reconstructive and Aesthetic surgeon, focusing on research and education in the field of Aesthetic surgery-and medicine. He is the medical director of MARA (medical aesthetic research academy). Offices of MARA are located in Vienna, Graz, 5* Imlauer Hotel Schloss Pichlarn and Beausoleil / France.
Having held a lot of international lectures and workshops and having received different awards in Aesthetic Medicine and aesthetic surgery he is a key opinion leader for different international companies. He has performed lots of different medical studies in the field of aesthetic medicine and plastic surgery at the Medical University, Department of Plastic, Reconstructive and Aesthetic Surgery.
Since several years he is the coordinator of the IMCAS Academy Alert Group of injectables and member of the IMCAS scientific board. Working worldwide as KOL for Euromedicom, 5cc, ASDS, ISAPS and many other international conferences he is also educating colleagues in anatomical labs.
Dr. Sara Sangha
Scientist, USA
Dr. Sara Sangha
Sara Sangha currently leads the U.S. Medical Affairs team for Allergan Aesthetics, an Abbvie company. In her role as Head of U.S. Aesthetics Medical Affairs, Sara is responsible for developing/executing Medical Affairs strategy for Facial Aesthetics (FAS) and Body Contouring therapeutic areas as well as management oversight of the field-based FAS and Body Contouring MSL teams. She has almost 20 years of experience in the pharmaceutical industry and has actively supported over 20 FDA approved product launches involving drugs and devices for aesthetics, medical dermatology, body contouring and plastic surgery.
Sara holds a Bachelor of Science degree in Pharmaceutical Sciences and a Ph.D. in Pharmacology and Toxicology from the University of California, Irvine. Prior to starting her pharmaceutical career, she also completed a post-doctoral fellowship program at Cleveland Clinic Lerner Research Institute in Cleveland, Ohio.
Sara began her industry career at Allergan Medical Affairs and supported Neuroscience, Eyecare and Urology functions prior to joining the Aesthetics team in 2007. She has held various roles in the aesthetic Medical Affairs organization leading the facial aesthetics, medical dermatology and PRM functions in the US.
Sara is very actively involved with the Equality, Equity, Diversity and Inclusion initiatives at Abbvie and represents Global Aesthetics Medical Affairs on the Allergan Aesthetics EED&I steering council. Sara believes that leadership and learning are indispensable to each other and strives to be a lifelong learner who is happy to share her experiences to help others.
Dr. Giuseppe Valacchi
Scientist, USA
Dr. Giuseppe Valacchi
Giuseppe Valacchi, PhD
David H. Murdock Distinguished Professor of Regenerative Medicine
Giuseppe Valacchi is David H. Murdock Distinguished Professor and Professor of Regenerative Medicine at North Carolina State University and Professor of Physiology at the University of Ferrara (Italy). In addition, he is International Scholar at Kyung Hee University, Seoul, South Korea.
His research has been focused in understanding the cellular and molecular redox mechanisms that define the tissues physio-pathological responses to endogenous and exogenous factors (Exposome) with special focus on skin and on the gut-skin axis.
He is author of over 370 peer reviewed international manuscripts, 20 book chapters, 4 books. He the President of the Society of Free Radical Research -Europe (SFRR-Europe). He has won several awards among them the Entelligence Award from Actelion, the Exposome award from Vichy, the University of Ferrara Bronze Medal (2020 from the Rector of Ferrara, Prof. Zauli). In 2018 he was awarded with the “Doctorate Honoris Causa” in Biochemistry and Pharmacy from the University of Buenos Aires. In 2019 he was the recipient of the Clinical Research Award from the SFRR-E and in 2021, he was awarded in Rome, as “Paladin of Health” from the Italian Ministry of Public Health and Education. In 2022, he was nominated and awarded with the title of “Faculty Scholar” at North Carolina State University, a title that recognizes and rewards emerging academic leaders who demonstrate significant achievement. From 2022 he is David H. Murdock Distinguished Professor in Regenerative Medicine at NCSU.
Editor in Chief: Archives in Biochemistry and Biophysics
Editor: Redox Experimental Medicine; Review Editor for Frontiers in Neuroscience; Frontiers in Pharmacology: Inflammation Pharmacology.
Associate Editor: Journal of Traditional and Complementary Medicine; Frontiers in Cellular Biochemistry, World Research Journal of Biochemistry; Mediators of Inflammation.
Member of Editorial Board: Scientific Reports; Antioxidants; Free Radicals in Biology and Medicine; Journal of Chemistry; BioFactors; Open Biochemistry Journal; Biomed Research International (Dermatology Subject); Frontiers in Inflammation Pharmacology; Genes and Nutrition; Journal of the Siena Academy of Science.
H index: 77 (Google Scholar), 62 (Scopus)
Dr. Virginia Vega
Skin Biologist, USA
Dr. Virginia Vega
Virginia (Vicky) Vega, PhD
Dr. Virginia Vega academic credentials include a Ph.D. in Cellular and Molecular Biology from Universidad de Concepción, Chile; a postdoctoral training in inflammation, stress response, and aging at Johns Hopkins University School of Medicine; and an Assistant Professor position at the University of California San Diego School of Medicine where she researched cellular transport and secretion, exosomes formation, cellular inflammation and pathogen responses.
Dr. Vega ‘s corporate experiences include five years as Research Investigator and Director of the Skin Biology Laboratory at SkinMedica®, an Allergan company. She optimized the usage of breakthrough technologies and innovative scientific concepts to lead new product conceptualization and development, scientific communications, KOL relationships, and physician education. She was also the Vice President of Research and Development and Physician Education at a San Diego based startup skincare company where, in only three years, she created a new physician-dispensed skincare line with a coherent scientific message and established physicians and KOL relationships.
In 2019, Dr. Vega’s applied her passion for transparent and effective skincare to found FlawlessCanvas Skincare where she is currently CEO and leads product development and commercialization.
Dr. Vega authored several peer reviewed communications and book chapters in the fields of inflammation, stress response, aging, and skincare. She presented her work at prestigious scientific meetings and her skincare products have been recognized with multiple awards for their high efficacy, innovation and safety.
Dr. Cristina Vicari
Plastic Surgeon, BRAZIL-SPAIN-PORTUGAL
Dr. Cristina Vicari
Dr. Cristina Vicari is a board-certified Plastic Surgeon with an international career spanning Brazil, Portugal, Spain and France. She completed her surgical training at the Navy Hospital Marcilio Dias and the Ivo Pitanguy Institute in Brazil, where she developed a strong foundation in both reconstructive and aesthetic plastic surgery.
With over 20 years of clinical experience, Dr. Vicari has worked extensively in public hospitals treating complex cases such as congenital malformations, burns, pediatric patients, and reconstructive challenges, while maintaining a parallel private aesthetic practice. She later expanded her professional activity to Europe, practicing in Portugal since 2011 and in Spain since 2019, where she currently co-directs SOFTOUCH, a private cosmetic plastic surgery clinic.
Dr. Vicari holds postgraduate training in Aesthetic Medicine, Orthomolecular Medicine, Thermography and Thermology, as well as an MBA in Business Administration. She earned her PhD with Cum Laude distinction at Hospital Vall d’Hebron (Universitát Autónoma de Barcelona), Spain, with research focused on microcirculation in abdominal plastic surgery using Infrared Thermography.
Her work is distinguished by the integration of Infrared Thermography into surgical planning, postoperative monitoring, and complication analysis in Plastic Surgery. In 2015, she co-founded a Thermographic Diagnostic Centerat Hospital Lusíadas, Lisbon, dedicated to the evaluation of chronic pain and complex functional conditions.
Dr. Vicari is an active member of several international medical societies and serves as a regular invited speaker at international aesthetic and plastic surgery meetings, where she shares her expertise on technology-driven diagnosis, surgical safety, and innovation in aesthetic medicine.
Dr. Julie Woodward
Oculofacial Surgeon, USA
Dr. Julie Woodward
Dr Julie Woodward is a Full Professor of Ophthalmology and Assoc Prof of Dermatology. She is the Chief of Oculofacial Surgery with over 25 years’ experience with injectables and aesthetic lasers. She is an author of >90 journal articles and textbook chapters and frequently speaker at national and international meetings. She serves on the Aesthetic Institute Association Medical Board and also served on the editorial board of 3 aesthetic journals. Quoted in several fashion magazines and the First female oculofacial surgeon on the cover of Plastic Surgery Practice Magazine as well as the Recipient of the Henry Baylis Award for contributions to cosmetic surgery 2022.
Dr. Heather Woolery Lloyd
Dermatologist, USA
Dr. Heather Woolery Lloyd
Heather Woolery-Lloyd, MD is an internationally recognized expert in skin of color. She lectures nationally and internationally on skin of color. Dr. Woolery-Lloyd participates extensively in clinical research, serving as an investigator for clinical trials with an emphasis on increasing the inclusion of skin of color patients. Dr. Woolery-Lloyd has authored over 70 peer-reviewed papers and is an active member of the Skin of Color Society and the American Academy of Dermatology (AAD), where she was honored with the AAD’s Presidential Citation for her commitment to education and research in dermatology.
Dr. Ahmed Zobi
Scientist, USA
Dr. Ahmed Zobi
Ahmed Zobi is the Founder and Chief Executive Officer of Syntr Health Technologies, Inc., a Southern California medical technology company pioneering automated systems for adipose tissue processing in regenerative medicine and surgery. With more than a decade of experience in biomedical engineering, micro and nanotechnology, biomechanics, and microfluidics, he has driven the conception, development, regulatory approval, and commercialization of the company’s flagship platform, the SyntrFuge System. Under his leadership, Syntr secured funding through the NIH SBIR grant program and achieved 510k regulatory clearance for clinical use, which enabled early commercial adoption in aesthetic, reconstructive, and wound care markets. His work supports safer and more predictable outcomes in procedures that rely on adipose tissue preservation, fat grafting, and soft tissue restoration, contributing to the scientific foundation of evidence-based practice in regenerative medicine.
Ahmed earned his Bachelor of Science in Biomedical Engineering with a specialization in micro and nanotechnology at the University of California Irvine. He later completed an Executive MBA from the Quantic School of Business and Technology. His early research at UC Irvine included work on a lab on a chip microfluidics project for adipose tissue processing which became the technical foundation for Syntr. In his role as CEO, he combines engineering depth with strategic leadership in product development, design transfer, regulatory planning, clinical collaboration, commercialization, and fundraising. He has been invited to events and hosted sessions where he spoke about building early stage MedTech companies, securing grant funding, navigating regulatory pathways, and managing commercialization in highly regulated markets. He has been featured in interviews on medical device entrepreneurship and was included in the Forbes Next 1000 list in 2021. Ahmed is committed to advancing the Orange County biotech ecosystem by advising MedTech start-ups and mentoring young founders who are developing new clinical and engineering based technologies.